Photodynamic therapy with redaporfin activated by pulsed laser light
Photodiagnosis and Photodynamic Therapy(2024)
摘要
Significance
Redaporfin is a photosensitizer under clinical trials for head and neck cancer. In previous work, a continuous light source was used in several tumor models, either in vitro or in vivo. However, the use of pulsed light (PL) sources can bring advantages to photodynamic therapy, such as higher penetration depths.
Approach
To study the influence of the light source in the efficacy of redaporfin-PDT, balb/c mice were inoculated with subcutaneous CT26 tumors. Redaporfin was activated using a PL source at 750 nm, with a repetition rate of 20 Hz and an energy per pulse of 24 mJ/cm2. Illumination time ranged from 5 to 15 min.
Results
The results show an acute inflammatory response followed by a fast shrinkage and necrosis of the tumors and no significant side effects.
Conclusions
The activation of redaporfin with PL leads to good response of the tumors and further studies are being held to optimize the treatment conditions.
更多查看译文
关键词
Photodynamic Therapy,Pulsed Light Source,Redaporfin
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要